Stocks and Investing
Stocks and Investing
Tue, February 28, 2017
[ 07:46 AM ] - United States, WOPRAI
[ 07:46 AM ] - United States, WOPRAI
[ 07:46 AM ] - United States, WOPRAI
[ 07:46 AM ] - United States, WOPRAI
[ 07:46 AM ] - United States, WOPRAI
[ 07:46 AM ] - United States, WOPRAI
[ 07:46 AM ] - United States, WOPRAI
[ 07:45 AM ] - United States, WOPRAI
[ 07:45 AM ] - United States, WOPRAI
[ 07:45 AM ] - United States, WOPRAI
[ 07:45 AM ] - United States, WOPRAI
[ 07:45 AM ] - United States, WOPRAI
[ 07:45 AM ] - United States, WOPRAI
[ 04:45 AM ] - United States, WOPRAI
[ 04:45 AM ] - United States, WOPRAI
[ 04:45 AM ] - United States, WOPRAI
[ 01:46 AM ] - United States, WOPRAI
[ 01:46 AM ] - United States, WOPRAI
[ 01:45 AM ] - United States, WOPRAI
[ 01:45 AM ] - United States, WOPRAI
[ 01:45 AM ] - United States, WOPRAI
[ 01:45 AM ] - United States, WOPRAI
[ 01:45 AM ] - United States, WOPRAI
[ 12:45 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Jason McCarthy Downgraded (BLUE) to Hold on, Feb 28th, 2017
Jason McCarthy of Maxim Group, Downgraded "bluebird bio, Inc." (BLUE) to Hold on, Feb 28th, 2017.
Jason has made no other calls on BLUE in the last 4 months.
There is 1 other peer that has a rating on BLUE. Out of the 1 peers that are also analyzing BLUE, all agrees with Jason's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Matthew Luchini of "BMO Capital" Initiated at Hold and Held Target at $61 on, Friday, November 11th, 2016
Contributing Sources